Kimberly A. Reed
Director · TAKEDA PHARMACEUTICAL CO LTD
Individual
- 2024
- Jul 6, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kimberly A. Reed files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Stewart Plump - $5.34M in TAK purchases and sales in the last 12 months
- Jeffrey Eckel - $5.27M in HASI purchases and sales in the last 12 months
- Julie So-Young Kim - $1.52M in TAK purchases and sales in the last 12 months
- Lauren Rusckowski Duprey - $1.45M in TAK purchases and sales in the last 12 months
- Nicola Deidre Petal Greenway - $957K in TAK purchases and sales in the last 12 months
- Teresa Marie Bitetti - $855K in TAK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kimberly A. Reed?
Kimberly A. Reed is a corporate insider, tracked as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kimberly A. Reed last file a Form 4?
The most recent primary Form 4 on record is dated 6 July 2026, one of 5 filings going back to 2024.
